Literature DB >> 16467126

Tubular kidney injury molecule-1 in protein-overload nephropathy.

Mirjan M van Timmeren1, Stephan J L Bakker, Vishal S Vaidya, Veronique Bailly, Theo A Schuurs, Jeffrey Damman, Coen A Stegeman, Joseph V Bonventre, Harry van Goor.   

Abstract

Kim-1, a recently discovered membrane protein, is undetectable in normal kidneys but markedly induced in proximal tubules after ischemic and toxic injury. The function of Kim-1 is unclear, but it is implicated in damage/repair processes. The Kim-1 ectodomain is cleaved by metalloproteinases and detectable in urine. We studied Kim-1 in a nontoxic, nonischemic, model of tubulointerstitial damage caused by acute proteinuria. Uninephrectomized (NX) rats received daily (ip) injections of 2 g BSA (NX+BSA, n = 12) or saline (NX, n = 6) for 3 wk. Kidneys were stained for various damage markers by immunohistochemistry (IHC). Kim-1 mRNA (RT-PCR, in situ hybridization), protein (IHC, Western blotting), and urinary Kim-1 (Luminex) were determined. Spatial relations between Kim-1 and other damage markers were studied by double labeling IHC. NX+BSA rats developed massive proteinuria (1,217 +/- 313 vs. 18 +/- 2 mg/day in NX, P < 0.001) and significant renal damage. Kim-1 mRNA was upregulated eightfold in NX+BSA (ratio Kim-1/beta-actin, 4.08 +/- 2.56 vs. 0.52 +/- 0.64 in NX, P < 0.001) and localized to damaged tubules. Kim-1 protein expression was markedly induced in NX+BSA (2.46 +/- 1.19 vs. 0.39 +/- 0.10% staining/field in NX, P < 0.001). Urinary Kim-1 was significantly elevated in NX+BSA (921 +/- 592 vs. 87 +/- 164 pg/ml in NX, P < 0.001) and correlated with tissue Kim-1 expression (r = 0.66, P =0.02). Kim-1 protein was found at the apical membrane of dilated nephrons. Kim-1 expression was limited to areas with inflammation (MØ), fibrosis (alpha-smooth muscle actin), and tubular damage (osteopontin), and only occasionally with tubular dedifferentiation (vimentin). These results implicate involvement of Kim-1 in the pathogenesis of proteinuria-induced renal damage/repair. Urinary Kim-1 levels may serve as a marker of proteinuria-induced renal damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467126     DOI: 10.1152/ajprenal.00403.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  60 in total

1.  Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction.

Authors:  G Chen; E A Bridenbaugh; A D Akintola; J M Catania; V S Vaidya; J V Bonventre; A C Dearman; H W Sampson; D C Zawieja; R C Burghardt; A R Parrish
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-01

2.  Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis.

Authors:  Muh Geot Wong; Yusuke Suzuki; Chiaki Tanifuji; Hisaya Akiba; Ko Okumura; Takeshi Sugaya; Tokunori Yamamoto; Satoshi Horikoshi; Si Yen Tan; Carol Pollock; Yasuhiko Tomino
Journal:  J Am Soc Nephrol       Date:  2007-12-19       Impact factor: 10.121

3.  Albumin and glycated albumin activate KIM-1 release in tubular epithelial cells through distinct kinetics and mechanisms.

Authors:  Ai Ing Lim; Loretta Y Y Chan; Sydney C W Tang; Kar Neng Lai; Joseph C K Leung
Journal:  Inflamm Res       Date:  2014-07-26       Impact factor: 4.575

4.  Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.

Authors:  Sushrut S Waikar; Venkata Sabbisetti; Johan Ärnlöv; Axel C Carlsson; Josef Coresh; Harold I Feldman; Meredith C Foster; Gudeta D Fufaa; Johanna Helmersson-Karlqvist; Chi-Yuan Hsu; Paul L Kimmel; Anders Larsson; Yumin Liu; Lars Lind; Kathleen D Liu; Theodore E Mifflin; Robert G Nelson; Ulf Risérus; Ramachandran S Vasan; Dawei Xie; Xiaoming Zhang; Joseph V Bonventre
Journal:  Nephrol Dial Transplant       Date:  2016-06-07       Impact factor: 5.992

5.  Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.

Authors:  Adam Whaley-Connell; Javad Habibi; Zachary Panfili; Melvin R Hayden; Sarika Bagree; Ravi Nistala; Safwan Hyder; Bennett Krueger; Vincent Demarco; Lakshmi Pulakat; Carlos M Ferrario; Alan Parrish; James R Sowers
Journal:  Am J Nephrol       Date:  2011-06-29       Impact factor: 3.754

Review 6.  Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application.

Authors:  Zubaida Al-Ismaili; Ana Palijan; Michael Zappitelli
Journal:  Pediatr Nephrol       Date:  2010-07-10       Impact factor: 3.714

7.  Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.

Authors:  Saranga Sriranganathan; Elena Tutunea-Fatan; Alina Abbasi; Lakshman Gunaratnam
Journal:  Mol Cell Biochem       Date:  2020-11-19       Impact factor: 3.396

8.  Age-related differences in susceptibility to cisplatin-induced renal toxicity.

Authors:  P Espandiari; B Rosenzweig; J Zhang; Y Zhou; L Schnackenberg; V S Vaidya; P L Goering; R P Brown; J V Bonventre; K Mahjoob; R D Holland; R D Beger; K Thompson; J Hanig; N Sadrieh
Journal:  J Appl Toxicol       Date:  2010-03       Impact factor: 3.446

9.  Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.

Authors:  Femke Waanders; Vishal S Vaidya; Harry van Goor; Henri Leuvenink; Kevin Damman; Inge Hamming; Joseph V Bonventre; Liffert Vogt; Gerjan Navis
Journal:  Am J Kidney Dis       Date:  2008-09-27       Impact factor: 8.860

10.  Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

Authors:  Vishal S Vaidya; Josef S Ozer; Frank Dieterle; Fitz B Collings; Victoria Ramirez; Sean Troth; Nagaraja Muniappa; Douglas Thudium; David Gerhold; Daniel J Holder; Norma A Bobadilla; Estelle Marrer; Elias Perentes; André Cordier; Jacky Vonderscher; Gérard Maurer; Peter L Goering; Frank D Sistare; Joseph V Bonventre
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.